Article: Nicotinamide Riboside Restores Mitochondrial Function and Improves Heart Failure with Preserved Ejection Fraction: Preclinical Findings

PrevNext
Cardiovascular Disease Cardiovascular Health Mitochondrial Health Preclinical

Nicotinamide Riboside Restores Mitochondrial Function and Improves Heart Failure with Preserved Ejection Fraction: Preclinical Findings

Synopsis

Heart Failure with Preserved Ejection Fraction (HFpEF) is a serious heart condition without effective treatments. In a mouse model of HFpEF, researchers found impaired mitochondrial fatty acid oxidation linked to excessive acetylation of key enzymes. This hyperacetylation resulted from low NAD+ levels caused by a faulty NAD+ salvage pathway and reduced sirtuin 3 expression. Similar defects in NAD+ biosynthesis genes were seen in human HFpEF heart tissue. Supplementing mice with NR or activating NAD+ biosynthesis improved mitochondrial function and reduced HFpEF symptoms. These results suggest mitochondrial dysfunction in HFpEF is linked to NAD+ deficiency and that restoring NAD+ is a promising therapy.

Journal

Circulation Research

Share

Read more

Digestive/Gut Health

Nicotinamide Riboside Restores Intestinal Health and Mitochondrial Function in Colitis: Preclinical Findings

SynopsisReduced levels of PGC1α, a key regulator of cellular energy, contribute to inflammatory bowel disease (IBD). In both mice with experimental colitis and humans with ulcerative colitis, NAD+ ...

Read more
Muscle Health

Nicotinamide Riboside Restores Exercise Capacity and Mitochondrial Function in Barth Syndrome: Preclinical Findings

SynopsisBarth syndrome, caused by tafazzin mutation, leads to mitochondrial dysfunction and severe exercise intolerance. In a Drosophila model, NR supplementation restored exercise capacity and mit...

Read more